Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $54.47 ($493K) on 2015-10-01, disclosed to the SEC on 2015-10-02.
Scheduled sale ($493k) by VP, Product Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.51 | 1,130 | $60K | 12.3% |
| 2 | $54.47 | 5,079 | $277K | 56.1% |
| 3 | $55.37 | 1,263 | $70K | 14.2% |
| 4 | $56.43 | 1,454 | $82K | 16.6% |
| 5 | $57.10 | 74 | $4K | 0.9% |
| Total | $54.81 avg | 9,000 |
| $493K |
| 100% |
| Filing → |
| KITE | SELL | 2015-12-03 | $687K | — | Filing → |
| KITE | SELL | 2015-11-04 | $640K | — | Filing → |
| KITE | SELL | 2015-09-03 | $466K | — | Filing → |